The Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are a critical source of non-dilutive financing for early-stage companies. The National Cancer Institute (NCI) SBIR Development Center provides funding, networking, and mentoring support for small businesses developing innovative cancer technologies. In fiscal year 2022, NCI SBIR will provide $182 million to small businesses to translate their innovation from lab to market.  

Join Princeton Innovation Center BioLabs, the National Cancer Institute (NCI) SBIR Development Center, the New Jersey Commission on Science, Innovation and Technology, and the Princeton Entrepreneurship Council, for a free program about funding opportunities available through the NCI SBIR Development Center. 

NCI SBIR Director Michael Weingarten and Program Director Monique Pond will discuss fundamental information on NCI SBIR/STTR funding, as well as commercialization resources and application tips. Judith Sheft, executive director of the New Jersey Commission on Science, Innovation and Technology, will moderate the event. 

You will learn about:

• SBIR/STTR eligibility requirements
• NIH SBIR/STTR process and new cancer-focused funding opportunities from NCI
• NCI SBIR/STTR initiatives such as the I-Corps at NIH Entrepreneurship Program, Applicant Assistant Program, etc.
• NCI Investor Initiative to help NCI SBIR-funding companies to connect with investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries
• Practical strategies on how to successfully submit competitive research proposals

You will have the opportunity to meet 1:1 with program directors at the conclusion of the program. If you would like to be considered for a one-on-one meeting, please contact Bryce Geiling by Tuesday, April 26, at [email protected] with a one-page summary of your company and technology.